Characteristics of study patients.
| Characteristics | Patients, n = 33 |
|---|---|
| Females | 31 (94%) |
| Mean age, yrs (range) | 14.11 (11.1–18.6) |
| Duration of symptoms, n* | |
| < 3 mo | 10 |
| > 3 mo, < 12 mo | 5 |
| > 12 mo | 10 |
| Does not remember | 8 |
| TMJ involvement, n | |
| Unilateral | 11 |
| Bilateral | 22 |
| JIA diagnosis, n | |
| Oligoarticular | 12 |
| Polyarticular | 16 |
| Systemic | 2 |
| Psoriatic | 1 |
| Undifferentiated** | 2 |
| Medication, n | |
| NSAID | 11 |
| Paracetamol | 2 |
| Sulfasalazine | 2 |
| Methotrexate | 15 |
| IACI*** | 1 |
| Systemic steroids | 0 |
| Biologics | 8 |
| No medication | 7 |
↵* Only orofacial symptoms. 25/33 patients were able to remember the duration of their orofacial symptoms.
↵** Subtype diagnosis was still unknown at the time of examination.
↵*** Intraarticular TMJ steroid injection within the past 3 months. TMJ: temporomandibular joint; JIA: juvenile idiopathic arthritis; NSAID: nonsteroidal antiinflammatory drugs; IACI: intraarticular corticosteroid injections.